MRNS
Dimensional Fund Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-29,201
| Closed | -$317K | – | 3439 |
|
2023
Q4 | $317K | Sell |
29,201
-2,888
| -9% | -$31.4K | ﹤0.01% | 3120 |
|
2023
Q3 | $258K | Hold |
32,089
| – | – | ﹤0.01% | 3169 |
|
2023
Q2 | $348K | Hold |
32,089
| – | – | ﹤0.01% | 3134 |
|
2023
Q1 | $221K | Hold |
32,089
| – | – | ﹤0.01% | 3184 |
|
2022
Q4 | $128 | Buy |
+32,089
| New | +$128 | ﹤0.01% | 3296 |
|
2022
Q3 | – | Sell |
-74,511
| Closed | -$360K | – | 3537 |
|
2022
Q2 | $360K | Sell |
74,511
-13,874
| -16% | -$67K | ﹤0.01% | 3140 |
|
2022
Q1 | $826K | Hold |
88,385
| – | – | ﹤0.01% | 3033 |
|
2021
Q4 | $1.05M | Buy |
88,385
+42,254
| +92% | +$502K | ﹤0.01% | 3021 |
|
2021
Q3 | $525K | Sell |
46,131
-42,776
| -48% | -$487K | ﹤0.01% | 3167 |
|
2021
Q2 | $1.6M | Buy |
88,907
+28,059
| +46% | +$503K | ﹤0.01% | 2933 |
|
2021
Q1 | $941K | Sell |
60,848
-2,369
| -4% | -$36.6K | ﹤0.01% | 3026 |
|
2020
Q4 | $771K | Buy |
63,217
+29,188
| +86% | +$356K | ﹤0.01% | 3026 |
|
2020
Q3 | $436K | Sell |
34,029
-130,062
| -79% | -$1.67M | ﹤0.01% | 3086 |
|
2020
Q2 | $417K | Sell |
164,091
-22,602
| -12% | -$57.4K | ﹤0.01% | 3111 |
|
2020
Q1 | $379K | Sell |
186,693
-36,866
| -16% | -$74.8K | ﹤0.01% | 3104 |
|
2019
Q4 | $483K | Sell |
223,559
-17,998
| -7% | -$38.9K | ﹤0.01% | 3136 |
|
2019
Q3 | $372K | Buy |
241,557
+25,279
| +12% | +$38.9K | ﹤0.01% | 3191 |
|
2019
Q2 | $898K | Buy |
216,278
+174,307
| +415% | +$724K | ﹤0.01% | 3075 |
|
2019
Q1 | $175K | Hold |
41,971
| – | – | ﹤0.01% | 3326 |
|
2018
Q4 | $120K | Sell |
41,971
-12,447
| -23% | -$35.6K | ﹤0.01% | 3345 |
|
2018
Q3 | $544K | Buy |
+54,418
| New | +$544K | ﹤0.01% | 3167 |
|
2018
Q2 | – | Sell |
-15,100
| Closed | -$58K | – | 3384 |
|
2018
Q1 | $58K | Hold |
15,100
| – | – | ﹤0.01% | 3310 |
|
2017
Q4 | $123K | Hold |
15,100
| – | – | ﹤0.01% | 3265 |
|
2017
Q3 | $89K | Buy |
+15,100
| New | +$89K | ﹤0.01% | 3289 |
|